seegerlab

RESEARCH GROUP SEEGER

RESEARCH GROUP SEEGER

university of zurich

RESEARCH GROUP SEEGER

RESEARCH GROUP SEEGER

university of zurich

RESEARCH GROUP SEEGER

RESEARCH GROUP SEEGER

university of zurich

RESEARCH GROUP SEEGER

RESEARCH GROUP SEEGER

university of zurich

RESEARCH GROUP SEEGER

RESEARCH GROUP SEEGER

university of zurich

RESEARCH GROUP SEEGER

RESEARCH GROUP SEEGER

university of zurich

RESEARCH GROUP SEEGER

RESEARCH GROUP SEEGER

university of zurich

RESEARCH GROUP SEEGER

RESEARCH GROUP SEEGER

university of zurich

our projects

MycoTransport

DrugEfflux

Sybodies

NestLink

Our mission

We are a team of creative, ambitious and friendly researchers who investigate membrane transport processes in pathogenic bacteria and develop innovative protein engineering tools. We combine the disciplines of structural biology, binder generation, protein biochemistry and microbiology to uncover molecular details of how membrane transport proteins expel antibiotics, shuttle siderophores and export lipids. Sybodies and NestLink enable us to target membrane transporters in the cellular context to develop rapid diagnostics, novel antibiotics and tailor-made research tools.
Congrats to Sille Remm for successfully defending her PhD thesis!🥳👩‍🎓 You did very well biting through this tough project! We're so proud of you!☺️☺️ https://t.co/QPUg0m7jaA seegerlab photo
(Please RT)

You like:
- bacteria ?
- ☀️& 🩴?
- adventurous & cool tweeps?

then --> Goa (India) for BMSV23, #EMBObacMorph23,
https://t.co/55lAJcyARj, 6-10 Geb, 2023 by @sunishk @dnarepairlab , submit abstracts asap https://t.co/MDdiDMaIWX
seegerlab photo
new release7

(X-ray) cystinosin from A. thaliana

7ZK1: w/ sybody and nanobody
7ZKW: w/ Cystine and sybody
7ZKZ: w/ two nanobodies

"Structural basis for proton coupled cystine transport by cystinosin"

Newstead lab. Nat. Commun.

https://t.co/c4TxEAdRvN
Closing the scientific program of the day with the Technologies session with four exciting presentations from ⁦ @mattia_zampieri⁩ ⁦ @lab_maier⁩ ⁦ @JWVeening⁩ lab and ⁦ @seegerlab⁩. What a day at the 2022 SSM meeting ! ⁦ @SwissMicrobehttps://t.co/JFy4RCMcQ7 seegerlab photo
Take a look at our latest structures - Ferroportin in complex with a first clinical-stage oral inhibitor vamifeport from @CSLVifor competing with its regulatory peptide hormone hepcidin. Exciting results within the iron-project funded by @NCCR_TransCure.

https://t.co/wCEmM1VPTT
Check out our newest review on #cryoEM (of membrane proteins) at 200 keV. Take home message: don’t treat your 200keV TEM only as a screening machine 😉. Fantastic work by @chancie_t and @rheinbergerj 👇🏼 https://t.co/gdSAZJf3LV https://t.co/aSmnkCPOQe seegerlab photo